# Myeloma MRI
## Issues

[^Laubach2019]: Laubach J. Initial therapy in older patients with multiple myeloma. N Engl J Med. 2019;380(22):2172-2173. https://search.proquest.com/docview/2232193627?accountid=46767. doi: http://dx.doi.org/10.1056/NEJMe1904372.

[^Lai2020]: Lai AYT, Riddell A, Barwick T, et al. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma. Eur Radiol. 2020;30(1):320-327. doi:10.1007/s00330-019-06281-x

[^NICE2016]: Cost-Effectiveness Analysis https://www.nice.org.uk/guidance/ng35/evidence/appendices-af-pdf-2306487278

[^Messiou2019]: Messiou C et al, Guidelines for Acquisition, Interpretation and Reporting of Whole-Body MRI in Myeloma. MY-RADS Radiology 2019; 291:5–13 • https://doi.org/10.1148/radiol.2019181949 •

[^Goldschmidt2016]: Goldschmidt N, Zamir L, Poperno A, Kahan NR, Paltiel O. Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis. J Am Board Fam Med. 2016;29(6):702-709. doi:10.3122/jabfm.2016.06.150393

[^Friese2009]: Friese C et al Leuk Lymphoma. 2009 March ; 50(3): 392–400. doi:10.1080/10428190902741471.



